Neomycin review scope document

The APVMA has commenced a reconsideration (hereafter referred to as review), of the registrations of products, which are oral, intramammary and injectable preparations of neomycin and their approved associated labels. This document defines the scope of the review. 

Was this page helpful?

Your feedback will be submitted to the APVMA anonymously. If you require a response, please contact us.